. Author manuscript; available in PMC: 2017 Jan 28.

Published in final edited form as: J Clin Psychiatry. 2017 Jan;78(1):e59–e63. doi: 10.4088/JCP.16m10819

Table 2.

Secondary Efficacy End Points: Mean Change in Outcome from Baseline to 2 months

Outcome	Waitlist (n=12)	SKY (ITT sample, n = 13)			SKY (Completer sample, n=11)
	Change From Baseline	Change From Baseline	Difference From Waitlist Control in Change from Baseline		Change From Baseline	Difference From Waitlist Control in Change from Baseline
	Mean (SE)	Mean (SE)	Mean (95% CI)	P Value	Mean (SE)	Mean (95% CI)	P Value
Scale
BDI, total score	−1.75 (2.56)	−17.23 (2.70)	15.48 (−8.34 to −22.62)	0.0101	−20.36 (2.76)	18.61 (−11.81 to −25.42	0.0043
BAI, total score	−.25 (1.48)	−5.44 (1.60)	−5.19 (−0.93 to −9.34)	0.0097	−6.48(1.75)	−6.23 (−1.39 to −11.07)	0.0005
HDRS-17, total score	.50 (1.87)	−9.77 (1.90)	10.27 (−5.04 to −15.50)	0.0032	−11.55 (2.00)	12.05 (−6.71 to −17.38)	0.0014
HDRS responders (%)^a	8.33%	46.15%		0.0730	54.54%		0.0271
HDRS remitters (%)^b	8.33%	30.77%		0.3217	36.36%		0.1550

Defined as patients having > 50% reduction from baseline HDRS-17 total score.

Defined as patients with HDRS-17 total score ≤ 7 and > 50% reduction in HDRS-17 total score from baseline.

Abbreviations: SKY = Sudarshan Kriya Yoga, ITT= intent-to-treat, HDRS-17 = 17-item Hamilton Depression Rating Scale, BDI = Beck Depression Inventory, BAI = Beck Anxiety Inventory